AI Tool for Early Stroke Diagnosis

Clinical Development of a Tool for Optimized Self- and Hetero-diagnosis of Stroke Using Artificial Intelligence: Stage1- Collection of Video-clinical Data in a Pragmatic Situation.

Recruiting N/A Interventional Study
Stroke, Cerebrovascular
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
300 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Other
Who this trial is looking for

This trial is looking for patients who might have had a stroke or a related event. Participants will take part in a test that involves doing some simple exercises while being recorded on video to help improve stroke diagnosis with the help of an app.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have suspected stroke or transient ischemic attack.
  • I am within 72 hours of my symptoms starting.
  • I will see a doctor again within 4 months.
  • I can give my consent to participate or my trusted person can give it for me.
  • I am covered by a health insurance plan.

You may not be able to join if

  • I do not speak or read French.
  • I am currently involved in another study that prevents me from participating.
  • I am under legal protection or guardianship.
  • I am pregnant, have just given birth, or am breastfeeding.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The study authors aim to form a collection of video-clinical data in a pragmatic situation to enable the development of relevant AI algorithms (for both hetero- and self-diagnosis modes). The aim is to optimize management through early diagnosis (self- and hetero-diagnosis) and thus to reduce sequelae disability. The study authors hypothesize that some stroke patients will be able to successfully…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients treated in the emergency department or hospitalized in the NICU at the CHU de Nîmes for suspected stroke or transient ischemic attack in the acute phase (\<72h), with or without motor deficit * Patient to be seen again in consultation within 4 months * Patient has giv…
Contacts

Anne WACONGNE

04.66.68.32.51

anne.wacongne@chu-nimes.fr

CONTACT